Hi Dave
@davybabyk
An excellent post mate, especially covering the background to
intraperitoneal delivery. I know that there are many on HC that appreciate your efforts, and the time you spend on research. IMU are certainly playing at the cutting edge in every way, and this is just another example (ie
CHECKvacc).
Yes, the Easter gifts keep coming from IMU don't they. This CF33 suite is stunning science, but I have said that so often I think most here are sick of me saying it.
One of the other points I have raised several times is the speed we could see a financially positive result. The
VAXINIA trials (yes plural) will enrol 100+ patients, so it is very possible that we will collect enough data (if positive) to attract significant interest for a deal. There are many examples of this happening before.
Yes, in the past it has generally been a long process.
This is different in so many ways. We have a virus that 'impacts' within days and its one we can track.
YF and LC couldn't be any clearer (without breaking FDA protocols), regarding what they are 'seeing' happening in the tumours.
This is a whole new game in cancer research, and we are witnessing the rules changing as we watch. Underestimate what IMU are achieving at your own cost.
As usual, this is not financial advice, just opinion.
(20min delay)